Stage 1 – Raw Material Production

MANUFACTURING FACILITY

1,500m² wet lab for non GMP production.

SKILLED WORKFORCE

Creation of 15 new and highly skilled, full time positions.

PRODUCTION CAPACITY

Production of Plasmid DNA capable of producing 40 million mRNA vaccine does each month – on demand.

TECHNOLOGY CAPABILITY

World-leading ‘wet lab’ facilities, state-of-the-art bioprocessing, chemical process technologies and proprietary manufacturing techniques.

JOBS CREATION

Over 1,000 Australian jobs for people in construction, manufacturing, specialist fields, bio-medical and consulting.

OPERATIONAL TIMEFRAME

Expected operationalisation within 6-months, estimated late-April 2022.